• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

National Institutes of Health

BioCorRx wins $5.6m grant for sustained release naltrexone implant

January 28, 2019 By Sarah Faulkner

BioCorRx updated logo

BioCorRx (OTC:BICX) announced this month that it won a two-year grant from the NIH’s National Institute on Drug Abuse to support the development of its sustained release naltrexone implant for the treatment of opioid use disorder. The grant includes $2.8 million for Feb. 1, 2019 to Jan. 31, 2020, followed by $2.8 million for the second […]

Filed Under: Drug-Device Combinations, Featured, Funding Roundup, Implants, Pharmaceuticals, Wall Street Beat Tagged With: BioCorRx, National Institutes of Health

NIH kicks off study of combo antibody HIV therapy

September 21, 2018 By Sarah Faulkner

NIH IV bag

The National Institutes of Health reported this week that it launched a clinical trial evaluating a combination of antibodies in people with HIV. The early-stage study is designed to assess whether periodic infusions of two HIV-specific antibodies are safe in people living with HIV. Researchers also plan to gather preliminary data assessing how effectively the […]

Filed Under: Clinical Trials, Featured, Pharmaceuticals, Research & Development Tagged With: National Institutes of Health

Researchers launch early-stage trial for nasal flu vaccine

September 18, 2018 By Sarah Faulkner

National Institutes of Health logo

Researchers at St. Louis University reported that an early-stage trial testing an experimental nasal flu vaccine in children and teens began enrolling participants this week. In the 50-person study, half of the participants will receive the investigational nasal vaccine and the other half will receive an inactive saline solution. All of the study’s participants are […]

Filed Under: Clinical Trials, Featured, Pharmaceuticals Tagged With: flugen, National Institutes of Health

NIH study finds daily aspirin does not prolong healthy lifespan

September 17, 2018 By Sarah Faulkner

Pills

In a 19,114-person trial supported by the National Institutes of Health, researchers found that daily low-dose aspirin did not prolong independent living in healthy older adults. Initial findings from the Aspree trial, which began in 2010, were published in The New England Journal of Medicine this week. The study involved participants who did not have […]

Filed Under: Clinical Trials, Featured, Pharmaceuticals Tagged With: National Institutes of Health

NIH launches precision medicine project to collect health data from one million volunteers

May 2, 2018 By Sarah Faulkner

NIH All of Us program

The National Institutes of Health will open national enrollment next week for its All of Us research program, aiming to collect health data from at least one million volunteers across the country. The project, which has been in beta for the last year, will request health and lifestyle data from volunteers using online surveys and […]

Filed Under: Featured, Pharmaceuticals, Research & Development Tagged With: National Institutes of Health

Study: PET imaging agent could help predict depression drug’s efficacy

April 6, 2018 By Sarah Faulkner

Imaging agent for depression

Researchers have identified a positron emission tomography imaging agent that could identify the patients that are more likely to benefit from a drug designed to treat major depressive disorder, according to a study published this month in The Journal of Nuclear Medicine. The C-DASB tracer targets a protein, 5-HTT, found in the part of a person’s […]

Filed Under: Featured, Imaging, Neurological, Pharmaceuticals Tagged With: National Institutes of Health

NIH launches $1.1B initiative to accelerate treatment options for opioid addiction

April 4, 2018 By Sarah Faulkner

National Institutes of Health logo

At the 2018 National Rx Drug Abuse and Heroin Summit today, National Institutes of Health director Dr. Francis Collins announced that the agency is launching the ‘Helping to End Addiction Long-term’ initiative. The NIH expects to spend nearly $1.1 billion in 2018 on research dedicated to expanding treatment options for people who are addicted to […]

Filed Under: Drug-Device Combinations, Featured, Pain Management, Pharmaceuticals, Research & Development Tagged With: National Institutes of Health

NIH study finds islet transplants improve quality of life for people with Type I diabetes

March 23, 2018 By Sarah Faulkner

National Institutes of Health logo

A Phase III trial funded by the National Institutes of Health found that quality of life for people with type I diabetes improved dramatically following transplantation of insulin-producing pancreatic islets, according to data published this week in the journal Diabetes Care. The 48-patient trial involved participants with hypoglycemia unawareness, a condition that renders them unable to […]

Filed Under: Clinical Trials, Diabetes, Featured, Research & Development Tagged With: National Institutes of Health

MIT study reveals the problem with bioresorbable stents

March 15, 2018 By Sarah Faulkner

MIT stent

Bioresorbable coronary scaffolds, designed to avoid the risks associated with the long-term implantation of metal stents, once captured the attention of medtech giants like Abbott (NYSE:ABT) and Boston Scientific (NYSE:BSX). But companies have since linked the use of these biodegradable polymer-based devices to a heightened risk of myocardial infarction and thrombosis, prompting Abbott to pull its Absorb […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals, Research & Development, Stents, Vascular Tagged With: abbott, Boston Scientific, Massachusetts Institute of Technology, National Institutes of Health

NIH: Asthma flare-ups not prevented by temporary increases to inhaled steroid dose

March 5, 2018 By Sarah Faulkner

asthma inhaler

Temporarily increasing the amount of inhaled steroids that young children take when their asthma symptoms worsen does not prevent severe flare-ups, according to a new study from the National Institutes of Health. The findings buck traditional medical practice involving kids with mild-to-moderate asthma. Asthma flare-ups are common among children with asthma and most doctors recommend […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals, Research & Development Tagged With: National Institutes of Health

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS